Inhibition of Rel/nuclear factor-κB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras-and p53-independent tumor development

M van Hogerlinden, G Auer, R Toftgård - Oncogene, 2002 - nature.com
M van Hogerlinden, G Auer, R Toftgård
Oncogene, 2002nature.com
In recent years a growth inhibitory role in skin for the Rel/NF-κB transcription factors has
been established, and the block of Rel/NF-κB signaling results in rapid development of
spontaneous skin cancer. The molecular mechanism underlying tumor development is
however unknown. In the present study, we show that inhibition of NF-κB signaling in mouse
skin by targeted expression of degradation resistant IκB-α generates transgenic
keratinocytes unable to arrest the cell cycle in response to DNA damage induced by γ …
Abstract
In recent years a growth inhibitory role in skin for the Rel/NF-κB transcription factors has been established, and the block of Rel/NF-κB signaling results in rapid development of spontaneous skin cancer. The molecular mechanism underlying tumor development is however unknown. In the present study, we show that inhibition of NF-κB signaling in mouse skin by targeted expression of degradation resistant IκB-α generates transgenic keratinocytes unable to arrest the cell cycle in response to DNA damage induced by γ-radiation. The results indicate that transgenic keratinocytes have a defect at the G1-S checkpoint whereas the G2-M checkpoint response was found to be intact. However, transgenic keratinocytes still respond by induction of the cyclin dependent kinase inhibitor p21 Cip1/Waf after exposure to γ-radiation. In the spontaneous skin tumors that develop in transgenic mice no mutations were found in the Ha-ras or p53 gene, suggesting that inhibition of NF-κB signaling in skin can induce cancer development independently of initiating mutations in the Ha-ras gene or additional mutations in the p53 gene. These findings demonstrate an involvement of NF-κB signaling in the DNA damage response and cell cycle checkpoint control in the skin.
nature.com